DUBLIN--(BUSINESS WIRE)--The "Hybrid Medicine Market - A Global and Regional Analysis: Focus on Therapeutic Area, Dosage Form, and Region - Analysis and Forecast, 2024-2033" report has been added to ...

The new drug, dubbed Spritam, was developed by Aprecia Pharmaceuticals to control seizures brought on by epilepsy. The FDA has previously approved medical devices - including prosthetics - that have ...

MASON, Ohio, July 22, 2025 /PRNewswire/ -- Aprecia, the global leader in 3DP (three-dimensional print) technology for commercial-scale pharmaceutical manufacturing, today announced that the U.S. Food ...